Related Experiment Video

Updated: Apr 20, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.2K

Exploration for the multi-effect of cardamom in's resistance to multiple myeloma

Zhao Zhihua1, Yang Jianping1, Sun Miaomiao2

  • 1Department of Pathology, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.

Pakistan Journal of Pharmaceutical Sciences
|November 21, 2014
PubMed

Insights

Cardamom extract inhibits multiple myeloma (MM) cell viability and proliferation. This natural compound shows potential as an anti-myeloma drug, offering a new avenue for cancer research.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products

Background:

  • Multiple myeloma (MM) is a cancer of plasma cells.
  • Current MM treatments have limitations and side effects.
  • Exploring natural compounds for anti-cancer properties is crucial.

Purpose of the Study:

  • To investigate the effects of cardamom extract on multiple myeloma cells.
  • To explore the anti-myeloma mechanisms of cardamom extract.
  • To evaluate cardamom extract's potential as a therapeutic agent.

Main Methods:

  • Cell viability assessed using CCK-8 assay.
  • Cell proliferation evaluated with EdU incorporation assay.
  • Cell cycle analysis performed via PI single-staining flow cytometry.
  • Apoptotic morphology observed using AO/EB double staining.

Main Results:

  • Cardamom extract significantly inhibited MM cell viability.
  • Cardamom extract suppressed MM cell proliferation.
  • Cardamom extract induced apoptosis in MM cells.
  • Cardamom extract demonstrated anti-myeloma activity.

Conclusions:

  • Cardamom extract possesses significant anti-myeloma properties.
  • Cardamom extract effectively inhibits MM cell viability and proliferation.
  • Cardamom extract warrants further investigation as a potential anti-myeloma therapeutic.

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

14.0K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K

Related Concept Videos

Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
12.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
74
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
8.0K